Avacta Group sells Coris to transition to therapeutics business
28th Jul 2025 11:38
(Alliance News) - Avacta Group PLC shares climbed on Monday, after it agreed to sell Coris Bioconcept SRL to 3B BlackBio Dx Ltd for GBP2.2 million upfront. Read More
| Price | 46.50p on 08-08-2025 at 05:00:01 |
|---|---|
| Change | 0.00p 0% |
| Buy | 0.00p |
| Sell | 0.00p |
| Last Trade: | Sell 21,752.00 at 46.00p |
| Day's Volume: | 0 |
| Last Close: | 46.50p |
| Open: | 0.00p |
| ISIN: | GB00BYYW9G87 |
| Day's Range | 0.00p - 0.00p |
| 52wk Range: | 27.25p - 77.50p |
| Market Capitalisation: | £186.82m |
| VWAP: | 0.00p |
| Shares in Issue: | 401.77m |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Avacta Group (AVCT) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 21,752 | 46.00p | Ordinary |
16:29:59 - 07-Aug-25 |
| Sell* | 10,000 | 46.10p | Ordinary |
16:29:14 - 07-Aug-25 |
| Sell* | 50,000 | 46.375p | Ordinary |
16:26:34 - 07-Aug-25 |
| Buy* | 819 | 46.9877p | Ordinary |
16:23:54 - 07-Aug-25 |
| Buy* | 31,921 | 46.99p | Ordinary |
16:21:58 - 07-Aug-25 |
| Unknown* | 39,456 | 46.00p | Ordinary |
16:21:24 - 07-Aug-25 |
| Sell* | 628 | 45.90p | Ordinary |
16:09:09 - 07-Aug-25 |
| Sell* | 5,885 | 45.90p | Ordinary |
15:59:35 - 07-Aug-25 |
| Sell* | 4,134 | 45.90p | Ordinary |
15:45:45 - 07-Aug-25 |
| Buy* | 42,901 | 46.58p | Ordinary |
15:39:35 - 07-Aug-25 |
Avacta Group (AVCT) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 30th Jul 2025 7:00 am | RNS | Avacta to Present at ESMO Congress |
| 28th Jul 2025 7:48 am | RNS | Agreement to Sell Coris Bioconcept SRL |
| 21st Jul 2025 7:00 am | RNS | Payment of Convertible Bond Installment |
| 17th Jul 2025 7:00 am | RNS | Equity fundraise of £3.25 million |
| 2nd Jul 2025 5:00 pm | RNS | Result of AGM |
| 2nd Jul 2025 7:00 am | RNS | Q2 2025 Business Update |
| 1st Jul 2025 7:00 am | RNS | Management Team Appointments |
| 30th Jun 2025 3:00 pm | RNS | Appointment of Zeus Capital as Joint Broker |
| 19th Jun 2025 7:00 am | RNS | New Response in Phase 1b Trial |
| 9th Jun 2025 5:15 pm | RNS | Posting of Annual Report and Revised Notice of AGM |